Q4 FY25 — 4 Jun 2025
AIMCOPEST Q4 FY25
AIMCOPEST faced a challenging FY25 with flat top-line and negative PAT, primarily due to intense price competition and lower realizations in its active ingredient division, despite strong volume growth. The brand business, however, showed resilience with 15% growth. The company is focusing on new product development, international registrations in Brazil, and cost management to return to profitability in FY26, targeting ₹225 crores in sales and 20% growth in its formulation business.
Read the full call






